365 related articles for article (PubMed ID: 18685434)
1. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
McGlasson DL; Romick BG; Rubal BJ
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
[TBL] [Abstract][Full Text] [Related]
2. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
Rosborough TK; Jacobsen JM; Shepherd MF
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
[TBL] [Abstract][Full Text] [Related]
3. Factor X and factor II activity levels do not always agree in warfarin-treated lupus anticoagulant patients.
Rosborough TK; Jacobsen JM; Shepherd MF
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):242-4. PubMed ID: 20182349
[TBL] [Abstract][Full Text] [Related]
4. Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant.
Crowl A; Schullo-Feulner A; Moon JY
Ann Pharmacother; 2014 Nov; 48(11):1479-83. PubMed ID: 25104566
[TBL] [Abstract][Full Text] [Related]
5. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.
Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy.
Costa IM; Serralheiro AI; Rodrigues M; Alves G; Falcão AC
Biomed Pharmacother; 2010 Feb; 64(2):130-2. PubMed ID: 20045627
[TBL] [Abstract][Full Text] [Related]
7. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
8. Clinically significant differences between point-of-care analysers and a standard analyser for monitoring the International Normalized Ratio in oral anticoagulant therapy: a multi-instrument evaluation in a hospital outpatient setting.
Moore GW; Henley A; Cotton SS; Tugnait S; Rangarajan S
Blood Coagul Fibrinolysis; 2007 Apr; 18(3):287-92. PubMed ID: 17413768
[TBL] [Abstract][Full Text] [Related]
9. [Role of laboratory monitoring in oral anticoagulant therapy].
D'Angelo G; Calvano D; Giardini C
Minerva Med; 1993 Jun; 84(6):313-22. PubMed ID: 8336839
[TBL] [Abstract][Full Text] [Related]
10. Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testing.
Baumann Kreuziger LM; Datta YH; Johnson AD; Zantek ND; Shanley R; Reding MT
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):232-6. PubMed ID: 24681704
[TBL] [Abstract][Full Text] [Related]
11. Maintenance control of oral anticoagulant therapy by an automated chromogenic substrate assay of factor X.
Erskine JG; Walker ID; Davidson JF
Clin Lab Haematol; 1982; 4(2):179-86. PubMed ID: 7116798
[TBL] [Abstract][Full Text] [Related]
12. Oral anticoagulant therapy and international normalized ratios in swine.
McGlasson DL; Brickey DA; Doe RH
Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
[TBL] [Abstract][Full Text] [Related]
13. Warfarin monitoring by an anticoagulant therapy factor (ATF).
Carroll WE; Jackson RD; Carroll TA
Res Commun Mol Pathol Pharmacol; 1998 Aug; 101(2):159-70. PubMed ID: 9821212
[TBL] [Abstract][Full Text] [Related]
14. [The international normalization ratio in the monitoring of oral anticoagulant therapy].
Sansores-García L; Majluf-Cruz AS; Vargas-Vorácková F; Labardini-Méndez J
Rev Invest Clin; 1993; 45(5):463-7. PubMed ID: 8134728
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
Crowther MA
Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
[TBL] [Abstract][Full Text] [Related]
16. Control of oral anticoagulation in patients with the antiphospholipid syndrome--influence of the lupus anticoagulant on International Normalized Ratio. Groupe Méthodologie en Hémostase du Groupe d'Etudes sur l'Hémostases et la Thrombose.
Robert A; Le Querrec A; Delahousse B; Caron C; Houbouyan L; Boutière B; Horellou MH; Reber G; Sié P
Thromb Haemost; 1998 Jul; 80(1):99-103. PubMed ID: 9684793
[TBL] [Abstract][Full Text] [Related]
17. Individual patient meta-analysis of self-monitoring of an oral anticoagulation protocol.
Perera R; Heneghan C; Fitzmaurice D;
J Heart Valve Dis; 2008 Mar; 17(2):233-8. PubMed ID: 18512497
[TBL] [Abstract][Full Text] [Related]
18. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant.
Rosborough TK; Shepherd MF
Pharmacotherapy; 2004 Jul; 24(7):838-42. PubMed ID: 15303447
[TBL] [Abstract][Full Text] [Related]
19. Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome.
Isert M; Miesbach W; Schüttfort G; Weil Y; Tirneci V; Kasper A; Weber A; Lindhoff-Last E; Herrmann E; Linnemann B
Ann Hematol; 2015 Aug; 94(8):1291-9. PubMed ID: 25859986
[TBL] [Abstract][Full Text] [Related]
20. [Control of oral anticoagulation: comparison between Quick and colorimetric factor X determination in 107 patients].
Lämmle B; Eichlisberger R; Hänni L; Bounameaux H; Marbet GA; Duckert F
Schweiz Med Wochenschr; 1979 Aug; 109(30):1115-9. PubMed ID: 472699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
